Skip to content

INNOVATION1 BIOTECH INC.: 10-Q/A filed 2022-02-01

What INNOVATION1 BIOTECH INC. reported in its quarterly report amendment filed 2022-02-01 (fiscal Q1 2022): 35 published measures, 73 facts as tagged in accession 0001477932-22-000537.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2022-02-01
Fiscal period
fiscal Q1 2022
Accession
0001477932-22-000537 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INNOVATION1 BIOTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-11-3084,378,669USD
At 2021-08-31181,886USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-11-3040,325,421USD
At 2021-08-31406,725USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-11-3044,053,248USD
At 2021-08-31-224,839USD
At 2020-11-30-2,927,850USD
At 2020-08-31-2,678,007USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-11-302,933,712USD
At 2021-08-31137,476USD
At 2020-11-3029,550USD
At 2020-08-3117,881USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-239,853USD91
2020-09-01 to 2020-11-30-237,268USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-353,764USD91
2020-09-01 to 2020-11-3011,669USD91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-303,080USD91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-09-01 to 2021-11-304,000,000USD91
2020-09-01 to 2020-11-300USD91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-850,000USD91
2020-09-01 to 2020-11-300USD91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-11-30-3,350,368USD
At 2021-08-31-2,973,628USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-09-01 to 2021-11-305,636,864shares91
2020-09-01 to 2020-11-30187,194shares91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-11-300USD
At 2021-08-31598USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-300USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-361,072USD91
2020-09-01 to 2020-11-30-57,175USD91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-11-302,949,162USD
At 2021-08-31168,476USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-09-01 to 2021-11-305,139USD91
2020-09-01 to 2020-11-3036,750USD91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-11-3029,325,421USD
At 2021-08-31406,725USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2021-09-01 to 2021-11-304,000,000USD91
2020-09-01 to 2020-11-300USD91

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-09-01 to 2021-11-30361,072USD91
2020-09-01 to 2020-11-3058,834USD91

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-11-300USD
At 2021-08-3117,000USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-301,659USD91

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-301,421USD91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-11-3020,020,239shares
At 2021-08-31188,616shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-11-3047,375,512USD
At 2021-08-312,745,906USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-11-300USD
At 2021-08-313,144USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-11-30103,298USD
At 2021-08-312,056USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-09-01 to 2021-11-3023,991USD91
2019-09-01 to 2019-11-30-269,849USD91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-09-01 to 2021-11-3012,464USD91
2020-09-01 to 2020-11-3012,003USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-30430USD91

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-11-04 to 2021-11-09178,000USD6

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-121,219USD91
2020-09-01 to 2020-11-30180,093USD91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-09-01 to 2021-11-3040,654,827USD91
2020-09-01 to 2020-11-300USD91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-30-3,080USD91

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-09-01 to 2021-11-300USD91
2020-09-01 to 2020-11-301,000USD91

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-09-01 to 2021-11-30-22,745USD91
2020-09-01 to 2020-11-3045,529USD91

Inspect the source

Entity
INNOVATION1 BIOTECH INC. / CIK 0001629205
Captured
2026-09-21T17:21:04.610Z
SEC response SHA-256
c5f3acfa863971b33b185130c620366a2f45cfd805cf4850d8be9be21b48d8fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001629205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))